Clinical trial
Evaluating the Effect of Mucinex 1200mg on Mucociliary and Cough Clearance During an Acute Respiratory Infection
NCT01114581 is registered in ClinicalTrials.gov with Reckitt Benckiser LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Effect of Mucinex 1200mg on Mucociliary and Cough Clearance During an Acute Respiratory Infection
- Lead sponsor
- Reckitt Benckiser LLC
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2010
- Completion date
- April 30, 2011
- Enrollment
- 38 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute respiratory infection